Barbara E. Murray, M.D.
Affiliations: | 1969 | Mathematics | Rice University, Houston, TX |
| 1969-1973 | University of Texas Southwestern Medical School, Dallas, TX, United States | ||
| 1973-1979 | Massachusetts General Hospital & Harvard Medical School, Boston, MA, United States | ||
| 1979-1980 | Infectious Disease | Armed Forces Research Institute of Medical Sciences | |
| 1980- | Internal Medicine | University of Texas Health Science Center at Houston, Houston, TX, United States |
Google:
"Barbara Murray"Parents
Sign in to add mentor| Robert C. Moellering, Jr | post-doc | 1978-1980 | Massachusetts General Hospital & Harvard Medical School |
Collaborators
Sign in to add collaborator| Don B. Clewell | collaborator | 1987- | |
| Gary M. Dunny | collaborator | 1998- | |
| Stanley L. Erlandsen | collaborator | 2004-2006 |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kebriaei R, Stamper KC, Singh KV, et al. (2020) Mechanistic Insights into the Differential Efficacy of Daptomycin plus β-Lactam Combinations against Daptomycin-Resistant Enterococcus faecium. The Journal of Infectious Diseases |
| Montealegre MC, Roh JH, Rae M, et al. (2016) Differential Penicillin-Binding Protein 5 (PBP5) Levels in the Enterococcus faecium Clades with Different Levels of Ampicillin Resistance. Antimicrobial Agents and Chemotherapy |
| La Rosa SL, Snipen LG, Murray BE, et al. (2015) A genomic virulence reference map of Enterococcus faecalis reveals an important contribution of phage03-like elements in nosocomial genetic lineages to pathogenicity in a Caenorhabditis elegans infection model. Infection and Immunity. 83: 2156-67 |
| Diaz L, Tran TT, Munita JM, et al. (2014) Whole-genome analyses of Enterococcus faecium isolates with diverse daptomycin MICs. Antimicrobial Agents and Chemotherapy. 58: 4527-34 |
| Rossi F, Diaz L, Wollam A, et al. (2014) Transferable vancomycin resistance in a community-associated MRSA lineage. The New England Journal of Medicine. 370: 1524-31 |
| Tran TT, Panesso D, Gao H, et al. (2013) Whole-genome analysis of a daptomycin-susceptible enterococcus faecium strain and its daptomycin-resistant variant arising during therapy. Antimicrobial Agents and Chemotherapy. 57: 261-8 |
| Munita JM, Arias CA, Murray BE. (2012) Enterococcal endocarditis: can we win the war? Current Infectious Disease Reports. 14: 339-49 |
| Debroy S, van der Hoeven R, Singh KV, et al. (2012) Development of a genomic site for gene integration and expression in Enterococcus faecalis. Journal of Microbiological Methods. 90: 1-8 |
| Nannini E, Murray BE, Arias CA. (2010) Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus. Current Opinion in Pharmacology. 10: 516-21 |
| Panesso D, Reyes J, Rincón S, et al. (2010) Molecular epidemiology of vancomycin-resistant Enterococcus faecium: a prospective, multicenter study in South American hospitals. Journal of Clinical Microbiology. 48: 1562-9 |